Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
XOMA Corp (NASDAQ:XOMA) 15 0 0
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) 3 0 0
Curis, Inc. (NASDAQ:CRIS) 8 0 0
Cerus Corporation (NASDAQ:CERS) 7 0 0
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) 10 0 0

Using the returns explained by Insider Monkey’s analyses, average investors should always pay attention to hedge fund and insider trading activity, and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) shareholders fit into this picture quite nicely.

Discover how hedge fund piggybacking can benefit you

Recommended Reading:

Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week

Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?

Hedge Fund Activity

Page 2 of 2